CLE may be helpful in the management of patients with BE because gastric, Barrett’s epithelium, and Barrett’s associated neoplastic changes can be diagnosed with high accuracy.
pCLE can be regarded as noninferior to endoscopic biopsy but, for its low PPV and sensitivity, may currently not replace standard biopsy techniques for the diagnosis of BE and associated neoplasia.
The addition of pCLE to high-definition white light imaging does not improve diagnostic accuracy nor clinical outcomes in patients undergoing ablation or resection for BE.
Endoscopists with minimal experience in CLE can effectively use this technology for targeted biopsy, decreasing the need for intense tissue sampling without lowering the diagnostic yield in detecting dysplasia.
Incident dysplasia can be more frequently detected by pCLE than by HD-WLE in BE. The higher dysplasia detection rate provided by pCLE could improve the efficacy of BE surveillance programs.
Real-time CLE and TB after HD-WLE can improve the diagnostic yield and accuracy for neoplasia and significantly impact in vivo decision-making by altering the diagnosis and guiding therapy.
CLE is able to provide virtual histology of early squamous cell cancers with a high degree of accuracy and can facilitate rapid diagnosis during routine endoscopy.
Scoring and quantification of CLE images may be useful for the differential diagnosis and determination of superficial invasion by squamous cell carcinoma.